The impact of driving time on participation in colorectal cancer screening with sigmoidoscopy and faecal immunochemical blood test

被引:5
|
作者
Berthelsen, Mona [1 ]
Berstad, Paula [1 ,7 ]
Randel, Kristin R. [1 ]
Hoff, Geir [1 ,2 ,3 ]
Natvig, Erik [1 ]
Holme, Oyvind [4 ,5 ]
Botteri, Edoardo [1 ,6 ]
机构
[1] Canc Registry Norway, Sect Colorectal Canc Screening, POB 5313 Majorstuen, N-0304 Oslo, Norway
[2] Telemark Hosp Trust, Dept Res & Dev, Ulefossvegen 55, N-3710 Skien, Norway
[3] Univ Oslo, Inst Clin Med, POB 1171 Blindern, N-0318 Oslo, Norway
[4] Sorlandet Hosp, Dept Med, POB 416 Lundsiden, N-4604 Kristiansand, Norway
[5] Univ Oslo, Inst Hlth & Soc, POB 1130 Blindern, N-1130 Oslo, Norway
[6] Canc Registry Norway, Dept Res, POB 5313 Majorstuen, N-0304 Oslo, Norway
[7] Canc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway
关键词
Colorectal cancer screening; Driving time; Faecal immunochemical test; Participation; Sigmoidoscopy; BREAST-CANCER; DISPARITIES; POPULATION; PREDICTORS; BARRIERS;
D O I
10.1016/j.canep.2022.102244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: High participation rates are important for a colorectal cancer (CRC) screening programme to be effective. Having a long travelling distance to screening centres may impede participation.Methods: We analysed the association between driving time from home address to screening centre and participation among individuals invited to screening with faecal immunochemical test (FIT) (n = 68,624) or sigmoidoscopy (n = 46,076) in a randomized trial in Norway in 2012-17. Two screening centres were involved. We fitted multiple logistic regression models, adjusted for demographic, socioeconomic and health characteristics, and reported odds ratios (OR) with 95% confidence intervals (CI). Results: Participation rates were 58.9 % (n = 40,445) for FIT and 51.9 % (n = 23,911) for sigmoidoscopy. In sigmoidoscopy, participation was 56.9 % and 47.9 % in those living < 20 and > 60 min by car from the screening centres, respectively. For each 10 min driving time increase, OR for participating in sigmoidoscopy screening was 0.93 (95 % CI 0.91-0.95). There was a significant difference between the two screening centres (p-value for heterogeneity <0.001). Participation in FIT screening were 61.2 % and 57.1 % in those with < 20 and > 60 min driving time, respectively, and the OR was 0.98 (95 % CI 0.96-0.99) for each 10 min increase (heterogeneity between screening methods, P-value <0.001). Among those with a positive FIT, compliance to colonoscopy was higher in those living < 20 compared to > 60 min from the centres (95.1 % vs. 92.9 %, respectively, OR 0.86; 95 % CI 0.77-0.93 for each 10 min increase).Conclusions: Driving time to screening centre was a significant predictor of participation, mainly in sigmoidoscopy. There were local differences in the impact of driving time on participation. Driving time also affected compliance to colonoscopy after a positive FIT. When planning a CRC screening programme, one should consider offering people living far from screening sites special assistance to facilitate their participation.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Screening for colorectal cancer with immunochemical faecal occult blood tests
    Faivre, Jean
    Dancourt, Vincent
    Lejeune, Catherine
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (12) : 967 - 973
  • [22] Cost-effectiveness of colorectal cancer screening programmes using sigmoidoscopy and immunochemical faecal occult blood test (Sept, 10.1177/0969141318789710, 2018)
    Senore, C.
    Hassan, C.
    Regge, D.
    JOURNAL OF MEDICAL SCREENING, 2021, 28 (02) : NP1 - NP1
  • [23] Patterns of participation over multiple rounds of faecal immunochemical test-based screening for colorectal cancer
    Osborne, Joanne M.
    Duncan, Amy
    Wilson, Carlene
    Turnbull, Deborah
    Flight, Ingrid
    Cole, Stephen R.
    Young, Graeme
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 27 - 27
  • [24] INCREASED PARTICIPATION IN COLORECTAL CANCER SCREENING DURING A PILOT OF FAECAL IMMUNOCHEMICAL TEST FOR HAEMOGLOBIN (FIT) IN ENGLAND
    Moss, S.
    Mathews, C.
    Day, T.
    Smith, S.
    Halloran, S. P.
    GUT, 2015, 64 : A1 - A1
  • [25] Impact of a new sampling buffer on faecal haemoglobin stability in a colorectal cancer screening programme by the faecal immunochemical test
    Grazzini, Grazia
    Ventura, Leonardo
    Rubeca, Tiziana
    Rapi, Stefano
    Cellai, Filippo
    Di Dia, Pietro P.
    Mallardi, Beatrice
    Mantellini, Paola
    Zappa, Marco
    Castiglione, Guido
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2017, 26 (04) : 285 - 291
  • [26] Characteristics of nonparticipants in a randomised colorectal cancer screening trial comparing sigmoidoscopy and faecal immunochemical testing
    Botteri, Edoardo
    Hoff, Geir
    Randel, Kristin R.
    Holme, Oyvind
    de Lange, Thomas
    Bernklev, Tomm
    Aas, Eline
    Berthelsen, Mona
    Natvig, Erik
    Kirkoen, Benedicte
    Knudsen, Markus D.
    Kvaerner, Ane S.
    Schult, Anna L.
    Ursin, Giske
    Jorgensen, Anita
    Berstad, Paula
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (03) : 361 - 371
  • [27] Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer
    Cole, SR
    Young, GP
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 175 (04) : 195 - 198
  • [28] Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT)
    Hoff, G
    Grotmol, T
    Thiis-Evensen, E
    Bretthauer, M
    Gondal, G
    Vatn, MH
    GUT, 2004, 53 (09) : 1329 - 1333
  • [29] Impact of time between faecal immunochemical tests in colorectal cancer screening on screening results: A natural experiment
    Ribe, Sara G.
    Botteri, Edoardo
    Loberg, Magnus
    Randel, Kristin R.
    Kalager, Mette
    Nilsen, Jens Aksel
    Gulichsen, Elisabeth H.
    Holme, Oyvind
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (07) : 1414 - 1424
  • [30] Faecal occult blood test as a screening test for colorectal cancer
    Janssens, JF
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2005, 68 (02): : 244 - 246